ENTL Entelos Regs

Entelos, Inc. (LSE:ENTL), announces today that James Karis, President and Chief Executive Officer, will make a corporate investor presentation at the Second Annual Piper Jaffray London Healthcare Conference at the Great Eastern Hotel, corner of Liverpool Street & Bishopsgate, London. Mr. Karis will give his presentation on Thursday, 21 June, 2007 at 3:40 p.m. (BST). The conference will feature presentations from more than 70 European and U.S. biopharmaceutical and medical technology companies. Company and investor participation is by invitation only. Further information about Entelos can be found on the company�s website at www.entelos.com. About Entelos Entelos, Inc. (www.entelos.com) is a US-based life sciences company applying next-generation predictive technologies and using 'virtual patients' and 'virtual mice' to revolutionize the way medicines are discovered, developed, and utilized. The Company leverages its proprietary in silico disease models, known as PhysioLab platforms, to help select and develop compounds, optimize clinical trials and combination therapies, evaluate in-licensing candidates, and better position products in competitive markets. In addition to internal drug programs in rheumatoid arthritis and women's health, Entelos partners with global pharmaceutical companies and provides customized technology and research services in cardiovascular diseases, asthma, obesity, diabetes, rheumatoid arthritis, hematopoeisis (anemia), cholesterol metabolism, and skin sensitization. The company recently launched realab�, a simulation tool to provide web-based access to Entelos� powerful PhysioLab platforms via the Internet.